Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

FDA

Latest News

February 26th 2025

FDA Accepts Supplemental New Drug Application for Teva, Medincell’s Uzedy for Bipolar I Disorder

By Don Tracy, Associate Editor

The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients with bipolar I disorder.

February 25th 2025

FDA Approves Prolacta Bioscience’s Surgifort for Infants Recovering from Gastroschisis Surgery

By Don Tracy, Associate Editor

February 25th 2025

FDA Grants Priority Review to Merck’s Keytruda for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

By Don Tracy, Associate Editor

February 18th 2025

Navigating Distrust: Pharma in the Age of Social Media

By Miranda Schmalfuhs

February 11th 2025

FDA Approves AbbVie’s Emblaveo for Complicated Intra-Abdominal Infections

By Don Tracy, Associate Editor

Trending on PharmExec

FDA’s Advisory Panel Votes in Favor of Updating Covid-19 Vaccine Shots to Target XFG Variant

CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo

WHO Prioritizes Three Experimental Treatments for Bundibugyo Ebola Strain

FDA's Timeline for DTC Prescription Drug Ad Oversight

Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms